OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artificial intelligence benefits all of humanity. AI is an extremely powerful tool that must be created with safety and human needs at its core. OpenAI is dedicated to putting that alignment of interests first — ahead of profit. To achieve our mission, we must encompass and value the many different perspectives, voices, and experiences that form the full spectrum of humanity. Our investment in diversity, equity, and inclusion is ongoing, executed through a wide range of initiatives, and championed and supported by leadership. At OpenAI, we believe artificial intelligence has the potential to help people solve immense global challenges, and we want the upside of AI to be widely shared. Join us in shaping the future of technology.

MDRC

MDRC is a nonprofit, nonpartisan education and social policy research organization dedicated to learning what works to improve programs and policies that affect the poor. MDRC's work is focused on five main policy areas: Promoting Family Well-Being and Child Development; Improving Public Education; Promoting Successful Transitions to Adulthood; Supporting Low-Wage Workers and Communities; Overcoming Barriers to Employment. Competitive Salaries and Excellent Benefits • Group major medical, hospital, dental, and life insurance • Prescription drug program • Pension plan, fully paid by MDRC • Generous vacation package • Paid family leave • Benefits for domestic partners • Adoption benefit

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR®), data-agnostic expertise, and a revolutionary engagement model, we deliver US and global real-world evidence, HEOR, and market access solutions that enable our partners to anticipate and address the evolving needs of payers, regulators, and stakeholders. Email solutions@genesisrg.com to find out more.

Oklahoma Medical Research Foundation

Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging. Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF’s critical research is helping people live longer, healthier lives, one discovery at a time. Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.

Notre Dame Research

Researchers at Notre Dame advance human understanding through research, scholarship, and creative endeavor in order to be a repository for knowledge and a powerful means for doing good in the world. Notre Dame Research supports and encourages innovation in more than forty core facilities, as well as in a number of key areas of research, including cancer, environmental change, global health, and many more, with faculty finding their homes in one of Notre Dame’s seven colleges or schools. Inspired by the University’s Catholic mission, Notre Dame’s world-class faculty and students are pursuing globally significant, solutions-oriented research as Notre Dame’s research enterprise grows in line with University President Rev. Robert A. Dowd's vision: “As a premier Catholic research university, our research and learning drive insights, innovation, and impact for good around the world.”